Pulmonary  ||| S:0 E:10 ||| JJ
artery  ||| S:10 E:17 ||| NN
catheters  ||| S:17 E:27 ||| NNS
After  ||| S:27 E:33 ||| IN
its  ||| S:33 E:37 ||| PRP$
introduction  ||| S:37 E:50 ||| NN
in  ||| S:50 E:53 ||| IN
1970 ||| S:53 E:57 ||| CD
,  ||| S:57 E:59 ||| ,
the  ||| S:59 E:63 ||| DT
use  ||| S:63 E:67 ||| NN
of  ||| S:67 E:70 ||| IN
the  ||| S:70 E:74 ||| DT
pulmonary  ||| S:74 E:84 ||| JJ
artery  ||| S:84 E:91 ||| NN
catheter  ||| S:91 E:100 ||| NN
became  ||| S:100 E:107 ||| VBD
a  ||| S:107 E:109 ||| DT
central  ||| S:109 E:117 ||| JJ
part  ||| S:117 E:122 ||| NN
of  ||| S:122 E:125 ||| IN
the  ||| S:125 E:129 ||| DT
management  ||| S:129 E:140 ||| NN
of  ||| S:140 E:143 ||| IN
critically  ||| S:143 E:154 ||| RB
ill  ||| S:154 E:158 ||| JJ
patients  ||| S:158 E:167 ||| NNS
in  ||| S:167 E:170 ||| IN
adult  ||| S:170 E:176 ||| NN
and  ||| S:176 E:180 ||| CC
pediatric  ||| S:180 E:190 ||| JJ
intensive  ||| S:190 E:200 ||| JJ
care  ||| S:200 E:205 ||| NN
units ||| S:205 E:210 ||| NNS
.  ||| S:210 E:212 ||| .
However ||| S:212 E:219 ||| RB
,  ||| S:219 E:221 ||| ,
because  ||| S:221 E:229 ||| IN
it  ||| S:229 E:232 ||| PRP
was  ||| S:232 E:236 ||| VBD
introduced  ||| S:236 E:247 ||| VBN
as  ||| S:247 E:250 ||| IN
a  ||| S:250 E:252 ||| DT
class  ||| S:252 E:258 ||| NN
II  ||| S:258 E:261 ||| NNP
device ||| S:261 E:267 ||| NN
,  ||| S:267 E:269 ||| ,
efficacy  ||| S:269 E:278 ||| VBG
for  ||| S:278 E:282 ||| IN
its  ||| S:282 E:286 ||| PRP$
safety  ||| S:286 E:293 ||| NN
and  ||| S:293 E:297 ||| CC
clinical  ||| S:297 E:306 ||| JJ
benefit  ||| S:306 E:314 ||| NN
did  ||| S:314 E:318 ||| VBD
not  ||| S:318 E:322 ||| RB
exist  ||| S:322 E:328 ||| VB
during  ||| S:328 E:335 ||| IN
the  ||| S:335 E:339 ||| DT
early  ||| S:339 E:345 ||| JJ
years  ||| S:345 E:351 ||| NNS
of  ||| S:351 E:354 ||| IN
use ||| S:354 E:357 ||| NN
.  ||| S:357 E:359 ||| .
This  ||| S:359 E:364 ||| DT
review  ||| S:364 E:371 ||| NN
describes  ||| S:371 E:381 ||| VBZ
the  ||| S:381 E:385 ||| DT
pulmonary  ||| S:385 E:395 ||| JJ
artery  ||| S:395 E:402 ||| NN
catheter  ||| S:402 E:411 ||| NN
and  ||| S:411 E:415 ||| CC
reviews  ||| S:415 E:423 ||| VBZ
the  ||| S:423 E:427 ||| DT
literature  ||| S:427 E:438 ||| NN
supporting  ||| S:438 E:449 ||| VBG
its  ||| S:449 E:453 ||| PRP$
use ||| S:453 E:456 ||| NN
.  ||| S:456 E:458 ||| .
A  ||| S:458 E:460 ||| DT
search  ||| S:460 E:467 ||| NN
of  ||| S:467 E:470 ||| IN
MEDLINE ||| S:470 E:477 ||| NNP
,  ||| S:477 E:479 ||| ,
PubMed ||| S:479 E:485 ||| NNP
,  ||| S:485 E:487 ||| ,
and  ||| S:487 E:491 ||| CC
the  ||| S:491 E:495 ||| DT
Cochrane  ||| S:495 E:504 ||| NNP
Database  ||| S:504 E:513 ||| NNP
was  ||| S:513 E:517 ||| VBD
made  ||| S:517 E:522 ||| VBN
to  ||| S:522 E:525 ||| TO
find  ||| S:525 E:530 ||| VB
literature  ||| S:530 E:541 ||| NN
about  ||| S:541 E:547 ||| IN
pulmonary  ||| S:547 E:557 ||| JJ
artery  ||| S:557 E:564 ||| NN
catheter  ||| S:564 E:573 ||| NN
use ||| S:573 E:576 ||| NN
.  ||| S:576 E:578 ||| .
Literature  ||| S:578 E:589 ||| NN
for  ||| S:589 E:593 ||| IN
both  ||| S:593 E:598 ||| DT
adult  ||| S:598 E:604 ||| NN
and  ||| S:604 E:608 ||| CC
pediatric  ||| S:608 E:618 ||| JJ
patients  ||| S:618 E:627 ||| NNS
was  ||| S:627 E:631 ||| VBD
reviewed ||| S:631 E:639 ||| VBN
.  ||| S:639 E:641 ||| .
Guidelines  ||| S:641 E:652 ||| NNS
published  ||| S:652 E:662 ||| VBN
by  ||| S:662 E:665 ||| IN
the  ||| S:665 E:669 ||| DT
Society  ||| S:669 E:677 ||| NNP
for  ||| S:677 E:681 ||| IN
Critical  ||| S:681 E:690 ||| NNP
Care  ||| S:690 E:695 ||| NNP
Medicine  ||| S:695 E:704 ||| NNP
and  ||| S:704 E:708 ||| CC
the  ||| S:708 E:712 ||| DT
American  ||| S:712 E:721 ||| NNP
Heart  ||| S:721 E:727 ||| NNP
Association  ||| S:727 E:739 ||| NNP
were  ||| S:739 E:744 ||| VBD
reviewed ||| S:744 E:752 ||| VBN
,  ||| S:752 E:754 ||| ,
including  ||| S:754 E:764 ||| VBG
further  ||| S:764 E:772 ||| JJ
review  ||| S:772 E:779 ||| NN
of  ||| S:779 E:782 ||| IN
references  ||| S:782 E:793 ||| NNS
cited ||| S:793 E:798 ||| VBD
.  ||| S:798 E:800 ||| .
The  ||| S:800 E:804 ||| DT
evidence  ||| S:804 E:813 ||| NN
supporting  ||| S:813 E:824 ||| VBG
the  ||| S:824 E:828 ||| DT
use  ||| S:828 E:832 ||| NN
of  ||| S:832 E:835 ||| IN
the  ||| S:835 E:839 ||| DT
pulmonary  ||| S:839 E:849 ||| JJ
artery  ||| S:849 E:856 ||| NN
catheter  ||| S:856 E:865 ||| NN
is  ||| S:865 E:868 ||| VBZ
mostly  ||| S:868 E:875 ||| RB
limited  ||| S:875 E:883 ||| VBN
to  ||| S:883 E:886 ||| TO
level  ||| S:886 E:892 ||| VB
IV  ||| S:892 E:895 ||| NNP
( ||| S:895 E:896 ||| -LRB-
nonrandomized ||| S:896 E:909 ||| UH
,  ||| S:909 E:911 ||| ,
historical  ||| S:911 E:922 ||| JJ
controls ||| S:922 E:930 ||| NNS
,  ||| S:930 E:932 ||| ,
and  ||| S:932 E:936 ||| CC
expert  ||| S:936 E:943 ||| NN
opinion ||| S:943 E:950 ||| NN
)  ||| S:950 E:952 ||| -RRB-
and  ||| S:952 E:956 ||| CC
level  ||| S:956 E:962 ||| NN
V  ||| S:962 E:964 ||| NNP
( ||| S:964 E:965 ||| -LRB-
case  ||| S:965 E:970 ||| NN
series ||| S:970 E:976 ||| NN
,  ||| S:976 E:978 ||| ,
uncontrolled  ||| S:978 E:991 ||| JJ
studies ||| S:991 E:998 ||| NNS
,  ||| S:998 E:1000 ||| ,
and  ||| S:1000 E:1004 ||| CC
expert  ||| S:1004 E:1011 ||| NN
opinion ||| S:1011 E:1018 ||| NN
) ||| S:1018 E:1019 ||| -RRB-
.  ||| S:1019 E:1021 ||| .
A  ||| S:1021 E:1023 ||| DT
higher  ||| S:1023 E:1030 ||| JJR
level  ||| S:1030 E:1036 ||| NN
of  ||| S:1036 E:1039 ||| IN
evidence  ||| S:1039 E:1048 ||| NN
supports  ||| S:1048 E:1057 ||| VBZ
the  ||| S:1057 E:1061 ||| DT
use  ||| S:1061 E:1065 ||| NN
of  ||| S:1065 E:1068 ||| IN
the  ||| S:1068 E:1072 ||| DT
pulmonary  ||| S:1072 E:1082 ||| JJ
artery  ||| S:1082 E:1089 ||| NN
catheter  ||| S:1089 E:1098 ||| NN
in  ||| S:1098 E:1101 ||| IN
selected  ||| S:1101 E:1110 ||| JJ
pediatric  ||| S:1110 E:1120 ||| JJ
patients ||| S:1120 E:1128 ||| NNS
,  ||| S:1128 E:1130 ||| ,
especially  ||| S:1130 E:1141 ||| RB
those  ||| S:1141 E:1147 ||| DT
with  ||| S:1147 E:1152 ||| IN
pulmonary  ||| S:1152 E:1162 ||| JJ
arterial  ||| S:1162 E:1171 ||| JJ
hypertension  ||| S:1171 E:1184 ||| NN
and  ||| S:1184 E:1188 ||| CC
shock  ||| S:1188 E:1194 ||| NN
refractory  ||| S:1194 E:1205 ||| NN
to  ||| S:1205 E:1208 ||| TO
standard  ||| S:1208 E:1217 ||| JJ
fluid  ||| S:1217 E:1223 ||| JJ
resuscitation  ||| S:1223 E:1237 ||| NN
and  ||| S:1237 E:1241 ||| CC
vasoactive  ||| S:1241 E:1252 ||| JJ
agents ||| S:1252 E:1258 ||| NNS
.  ||| S:1258 E:1260 ||| .
There  ||| S:1260 E:1266 ||| EX
are  ||| S:1266 E:1270 ||| VBP
no  ||| S:1270 E:1273 ||| DT
data  ||| S:1273 E:1278 ||| NNS
to  ||| S:1278 E:1281 ||| TO
suggest  ||| S:1281 E:1289 ||| VB
that  ||| S:1289 E:1294 ||| DT
use  ||| S:1294 E:1298 ||| NN
of  ||| S:1298 E:1301 ||| IN
the  ||| S:1301 E:1305 ||| DT
pulmonary  ||| S:1305 E:1315 ||| JJ
artery  ||| S:1315 E:1322 ||| NN
catheter  ||| S:1322 E:1331 ||| NN
increases  ||| S:1331 E:1341 ||| NNS
mortality  ||| S:1341 E:1351 ||| NN
in  ||| S:1351 E:1354 ||| IN
children ||| S:1354 E:1362 ||| NNS
.  ||| S:1362 E:1364 ||| .
